New Genetic Test Guidance Narrows Focus To Mutation Marker Assays

FDA is narrowing the focus of its proposed guidelines for manufacturers of gene-based tests from its original 2003 draft in response to comments from industry members and scientists, according to a revised 1draft guidance document issued Feb. 9